The Rising Problem of Obesity in America
Right now, America is dealing with a growing obesity problem. According to the Centers for Disease Control and Prevention (CDC), in 2017-2018, 42.4 percent of adults in the U.S. were obese and an even larger number are overweight. We keep hearing about traditional weight loss methods such as healthy eating, regular exercise, and behavioral change. Despite these regiments, obesity keeps rising. This prompts the question: Are these old methods enough for most people?
Maybe you’re reading this because diet and exercise alone haven’t helped you lose weight and keep it off. If that’s the case, remember: It’s not your fault. Weight management is complicated. Factors such as genes, our environment, filled with tasty, high-calorie foods, and lifestyle all affect how well we can lose weight and keep it off. For some people, diet and exercise aren’t enough to fight these obstacles.
Tirzepatide: A New Weight Loss Solution
At Rivas Medical Weight Loss, we know these challenges well and are committed to using the newest obesity treatments to help our patients. We’re excited to already offer the compounded version of Tirzepatide, a promising new weight loss medication.
Tirzepatide isn’t officially FDA-approved for weight loss yet, but we can still prescribe it “off-label” until it is. The FDA has recently given Tirzepatide Fast Track status for its use in adults who are obese or overweight with other weight-related health problems.
Our patients are seeing fantastic results with Tirzepatide. They’re losing a lot of weight with no significant side effects. It is indeed proving to be an effective and easy-to-tolerate weight loss tool.
Scientific Evidence Backing Tirzepatide
Tirzepatide is an injectable drug that patients use once a week. It has shown promise in clinical trials. The SURMOUNT-2 trial, for example, which studied how well and how safely Tirzepatide works for long-term weight management, reported amazing results.
An impressive 51.8 percent of participants on Tirzepatide lost at least 15 percent of their body weight, and 34 percent lost at least 20 percent. Compare these results to a placebo: 2.6 percent and 1 percent, respectively. Plus, patients on Tirzepatide in the trial saw much better improvements in important health measures such as blood pressure, fasting triglycerides, HDL-cholesterol and non-HDL-cholesterol compared to placebo.
The Future of Treating Obesity
New treatments such as Tirzepatide might change how we treat obesity. These new options could match the results of weight loss surgery without the associated risks and difficulties.
Looking at these new treatments, it’s possible that a non-surgical intervention such as using Tirzepatide could replace weight loss surgery as the go-to treatment within the next few years. In fact, we’ve treated many patients who’ve had weight loss surgery but sadly couldn’t keep the weight off over time.
Everyone’s weight loss journey is different. The best treatment will take individual needs and situations into account. Some people might do well with just lifestyle changes, while others might need extra help from medications.
As obesity treatment progresses, we can look forward to having more tools to manage our weight. As always, any decisions about weight loss methods should be made with healthcare professionals, ensuring a personalized approach that best suits personal health goals.